Study Design for Identification of Treatment-Associated Mutations From Exome Sequencing of Serial Plasma Samples. Plasma was collected before and at multiple time points during and after treatment of cancer patients. Mutations were identified across the plasma samples and increases in relative abundance were noted. Cataloguing of similar data across large cohorts could identify genes or pathways with recurrent mutations that arise under the selective pressure of specific treatments.